I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 19% ± 2% | |
| oligodendrocyte | 3 studies | 16% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 19% ± 2% | |
| oligodendrocyte | 3 studies | 16% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2160.82 | 1445 / 1445 | 100% | 39.92 | 183 / 183 |
| ovary | 100% | 2155.40 | 180 / 180 | 100% | 27.82 | 430 / 430 |
| prostate | 100% | 2045.62 | 245 / 245 | 100% | 25.54 | 501 / 502 |
| brain | 100% | 1965.96 | 2640 / 2642 | 100% | 35.86 | 704 / 705 |
| breast | 100% | 1900.27 | 459 / 459 | 100% | 33.07 | 1115 / 1118 |
| skin | 100% | 2777.16 | 1809 / 1809 | 99% | 36.45 | 469 / 472 |
| lung | 99% | 1611.11 | 574 / 578 | 100% | 32.16 | 1154 / 1155 |
| thymus | 100% | 2027.12 | 653 / 653 | 99% | 23.86 | 600 / 605 |
| uterus | 100% | 2152.33 | 170 / 170 | 99% | 25.53 | 453 / 459 |
| kidney | 100% | 1308.01 | 89 / 89 | 98% | 21.51 | 886 / 901 |
| pancreas | 99% | 947.93 | 326 / 328 | 99% | 19.66 | 176 / 178 |
| bladder | 100% | 2077.05 | 21 / 21 | 98% | 24.09 | 495 / 504 |
| adrenal gland | 100% | 1674.72 | 258 / 258 | 98% | 19.35 | 225 / 230 |
| stomach | 100% | 1381.19 | 359 / 359 | 97% | 23.68 | 278 / 286 |
| intestine | 100% | 1977.72 | 966 / 966 | 96% | 20.06 | 508 / 527 |
| liver | 100% | 973.19 | 226 / 226 | 94% | 13.77 | 382 / 406 |
| blood vessel | 100% | 1939.11 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.50 | 29 / 29 |
| spleen | 100% | 1699.51 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 25.01 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 14.34 | 1 / 1 |
| adipose | 100% | 2110.26 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 21.48 | 78 / 80 |
| heart | 97% | 1199.58 | 835 / 861 | 0% | 0 | 0 / 0 |
| muscle | 89% | 608.62 | 711 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 82% | 1116.33 | 761 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000423 | Biological process | mitophagy |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RIMOC1 |
| Protein name | RAB7A-interacting MON1-CCZ1 complex subunit 1 (UPF0600 protein C5orf51) |
| Synonyms | C5orf51 |
| Description | FUNCTION: Plays an important role in the removal of damaged mitochondria via mitophagy by controlling the stability and localization of RAB7A. Required for the recruitment of RAB7A and ATG9A vesicles to damaged mitochondria and promotes the stability of RAB7A by inhibiting its proteasomal degradation during mitophagy. . |
| Accessions | A6NDU8 ENST00000381647.7 |
